New combo therapy may save bladders in bladder cancer patients

NCT ID NCT07402317

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a three-step treatment for muscle invasive bladder cancer: chemotherapy, then a minimally invasive surgery to remove the tumor, followed by radiation. The goal was to treat the cancer while keeping the bladder intact, which could improve quality of life compared to standard bladder removal. The study included 97 adults with early-stage muscle invasive bladder cancer and looked at how well the cancer responded and how long patients remained cancer-free.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
chemotherapy (neoadjuvant), followed by transurethral resection of bladder tumor, then radiotherapy
What this could lead to
If successful, this approach could offer a way to treat muscle invasive bladder cancer without removing the bladder, potentially improving quality of life for patients.
What could go wrong
This is a single-center, non-randomized study with only 97 participants, so results may not apply to all patients. The cancer may still recur, and some patients may eventually need bladder removal.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER TREATMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Azhar Assiut faculty of medicine

    Asyut, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.